Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹151 Cr
Revenue (TTM)
₹173 Cr
Net Profit (TTM)
₹12 Cr
ROE
12.1 %
ROCE
14.7 %
P/E Ratio
12.8
P/B Ratio
--
Industry P/E
36.2
EV/EBITDA
--
Div. Yield
0.6 %
Debt to Equity
0.4
Book Value
₹53.5
EPS
₹4.9
Face value
10
Shares outstanding
19,337,443
CFO
₹-13.13 Cr
EBITDA
₹77.55 Cr
Net Profit
₹46.38 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
QMS Medical
| -12.9 | -11.4 | -17.0 | -13.3 | -18.4 | -- | -- |
|
BSE Sensex
| -12.0 | -9.7 | -12.2 | -1.2 | 8.7 | 8.4 | 11.6 |
|
BSE Healthcare
| -2.6 | -1.7 | -3.7 | 3.2 | 25.2 | 15.5 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
QMS Medical
| -19.1 | -13.3 | -28.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
QMS Medical
|
78.0 | 150.8 | 173.0 | 13.5 | 12.9 | 12.1 | 12.8 | -- |
| 251.1 | 143.6 | 34.5 | -3.4 | -5.4 | -48.6 | -- | 10.5 | |
| 57.0 | 49.3 | 38.4 | 3.3 | -- | 19.6 | 14.8 | 2.1 | |
| 217.7 | 414.5 | 135.7 | 16.1 | -- | 36.8 | 25.7 | 6.5 | |
| 122.1 | 167.9 | 43.1 | 6.6 | -- | 40.6 | 25.3 | 2.6 | |
| 134.3 | 74.0 | 35.4 | 5.8 | 15.4 | 17 | 12.8 | 1.8 | |
| 237.8 | 229.5 | 143.3 | 10.6 | 3.5 | 5.4 | 21.6 | 1.2 | |
| 1,240.9 | 12,584.8 | 1,781.6 | 341.3 | 19.8 | 12.4 | 36.2 | 4.2 | |
| 73.5 | 96.7 | 79.3 | 8.6 | 13.0 | 30.6 | 11.3 | 3.1 | |
| 191.0 | 337.2 | 92.4 | 4.7 | -- | 4.9 | 71.6 | 3.4 |
No Review & Analysis are available.
Other human health activities
Incorporated
2017
Chairman
Mahesh Makhija
Managing Director
Mahesh Makhija
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about QMS Medical Allied Services Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of QMS Medical Allied Services Ltd is ₹78.00 (NSE) as of 20-Mar-2026 IST. QMS Medical Allied Services Ltd has given a return of -18.38% in the last 3 years.
The P/E ratio of QMS Medical Allied Services Ltd is 12.80 times as on 20-Mar-2026, a 65 discount to its peers’ median range of 36.20 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
23.21
|
2.63
|
|
2023
|
36.58
|
3.28
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
|
2020
|
0.00
|
0.00
|
The 52-week high and low of QMS Medical Allied Services Ltd are Rs 112.70 and Rs 68.95 as of 21-Mar-2026.
QMS Medical Allied Services Ltd has a market capitalisation of ₹ 151 Cr as on 20-Mar-2026. As per SEBI classification, it is a Large Cap company.
Before investing in QMS Medical Allied Services Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹2.00
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.